COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20130917014693N13


Column Value
Trial registration number IRCT20130917014693N13
Full text link
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Afshin Zarghi

Contact
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

mpd@sbmu.ac.ir

Registration date
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-11-06

Recruitment status
Last imported at : Jan. 21, 2023, midnight
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Open label

Center
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Age more than 18 years old Severe acute respiratory injury with coronavirus infection symptoms during 10 days ago who needed for hospital admission infection with COVID-19 wich confirmed with nasal RT_PCR test or CT-scan imaging Mild to moderate acute respiratory distress syndrome No more than 24 hours have passed since their admission to the study. The patient should not be under aggressive mechanical respiration when entering the study. Consent to participate in the study.

Exclusion criteria
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dissatisfaction of the patient or the patient's legal companion Pregnancy and lactation Chronic hemodialysis Heart failure patients Severe vasoplegic shock Pulmonary edema due to other causes like heart failure , cirrhosis, chronic kidney failure Not administrating corticosteroid more than 24 hours after beginning ARDS Severe hypoxemia If the patient expires lower than 3 days after beginning of corticosteroids

Number of arms
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Shahid Beheshti University of Medical Sciences

Inclusion age min
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe disease at enrollment

Severity scale
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

74

primary outcome
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mortality ratio of patients with acute respiratory distress syndrome due to covid-19

Notes
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 1

Arms
Last imported at : Nov. 7, 2021, 3:03 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "1000 miligrams of methylprednisolone every 24 hours for 3 days then 1 mg/kg every 12 hours for 10 days", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "1 mg/kg every 12 hours for 10 days", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}]